MESSAGE FOR THE CLINIC
- Astodrimer gel is safe and superior to placebo in treating patients
with bacterial vaginosis.
- Unique features of astodrimer gel include satisfactory effectiveness,
well-endured safety profile, negligible rate of vulvovaginal
candidiasis, topical administration, reduced systemic exposure,
anti-biofilm activity, non-antibiotic mechanism of action and absence
of antibiotic resistance.
- Astodrimer gel may represent a promising alternative therapy to
patients who fail to respond or intolerant to various conventional
antibiotics.